As of January 22, 2025, Kala Pharmaceuticals (KALA) has a market cap of $36.532 million USD. According to our data, Kala Pharmaceuticals is ranked No.8332 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $36.53 M |
10.81%
|
Dec 31, 2024 | $32.97 M |
-0.86%
|
Dec 29, 2023 | $33.25 M |
-81.65%
|
Dec 30, 2022 | $0.18 B |
-36.94%
|
Dec 31, 2021 | $0.29 B |
-82.15%
|
Dec 31, 2020 | $1.61 B |
83.74%
|
Dec 31, 2019 | $0.88 B |
-24.54%
|
Dec 31, 2018 | $1.16 B |
-73.55%
|
Dec 29, 2017 | $4.39 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Alcon
ALC
|
$43.91 B |
-0.001 M
|
Switzerland
|
Bausch + Lomb
BLCO
|
$6.01 B |
0.000 M
|
Canada
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Novartis
NVS
|
$196.27 B |
-0.007 M
|
Switzerland
|
Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
Johnson & Johnson
JNJ
|
$349.75 B |
0.001 M
|
USA
|
AbbVie
ABBV
|
$299.00 B |
-0.007 M
|
USA
|
Glaukos
GKOS
|
$8.83 B |
0.000 M
|
USA
|
Ocular Therapeutix
OCUL
|
$1.26 B |
-0.000 M
|
USA
|
EyePoint Pharmaceuticals
EYPT
|
$0.60 B |
-0.000 M
|
USA
|
Clearside Biomedical
CLSD
|
$72.42 M |
-0.000 M
|
USA
|
Market Cap | = | KALA Stock Price | * | KALA Shares Outstanding |
= | $7.69 | * | 4.75 M | |
= | $36.53 M |